New Data from Qsight Market View reveals that U.S. patients spent $3.08 billion on energy-based devices (EBD) procedures in 2023—nearly matching dermal fillers’ $3.18 billion. EBD procedures are set to close the spending gap with dermal fillers, solidifying their position as a preferred choice for achieving natural-looking cosmetic results.With EBD on track to close the spending gap with dermal fillers, it positions the devices as favorable for natural-looking cosmetic procedures and outcomes.Courtesy of Guidepoint Qsight
Log in to view the full article
New Data from Qsight Market View reveals that U.S. patients spent $3.08 billion on energy-based devices (EBD) procedures in 2023—nearly matching dermal fillers’ $3.18 billion. EBD procedures are set to close the spending gap with dermal fillers, solidifying their position as a preferred choice for achieving natural-looking cosmetic results.With EBD on track to close the spending gap with dermal fillers, it positions the devices as favorable for natural-looking cosmetic procedures and outcomes.Courtesy of Guidepoint Qsight
Dermal fillers, particularly hyaluronic acid fillers, are commonly used for facial volume and shaping, while EBD are used for skin tightening, fat reduction and collagen stimulation. While EBD and dermal filler procedures vary in longevity and maintenance, Erik Haines, Guidepoint Qsight’s managing director, says the two serve categorically different aesthetic objectives depending on the specific type of EBD device or dermal filler involved.
According to a NLM study, it's recommended to use EBD before HA filler injection to reduce the risk of filler degradation.
While this recommendation could explain why EBD is being used as widely as filler, Haines says the narrowing difference between the two segments has been driven by stagnating growth in dermal filler sales over the past few years, as well as innovations in EBD enabling skin rejuvenation and resurfacing.
“Stagnating growth in dermal filler procedures, which have historically been dominated by hyaluronic acid filler treatments, may be indicative of a shift in consumer preferences toward more natural-looking cosmetic procedures and outcomes,” says Haines.
The competition between EBD and dermal fillers demonstrates a shift in patient demand for non-surgical and minimally invasive aesthetics that pose little to no downtime while addressing an array of skin concerns.
With EBD on track to close the spending gap with dermal fillers, it positions the devices as favorable for natural-looking cosmetic procedures and outcomes.Courtesy of Guidepoint Qsight
